LCBVX
Price
$39.25
Change
+$0.08 (+0.20%)
Updated
Jun 2 closing price
Net Assets
2.27B
VIVIX
Price
$67.30
Change
+$0.33 (+0.49%)
Updated
Jun 3 closing price
Net Assets
183.65B
Interact to see
Advertisement

LCBVX vs VIVIX

Header iconLCBVX vs VIVIX Comparison
Open Charts LCBVX vs VIVIXBanner chart's image
ClearBridge Large Cap Value R
Price$39.25
Change+$0.08 (+0.20%)
VolumeN/A
Net Assets2.27B
Vanguard Value Index I
Price$67.30
Change+$0.33 (+0.49%)
VolumeN/A
Net Assets183.65B
LCBVX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LCBVX vs. VIVIX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCBVX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. LCBVX (2.27B). VIVIX pays higher dividends than LCBVX: VIVIX (2.29) vs LCBVX (0.71). LCBVX was incepted earlier than VIVIX: LCBVX (11 years) vs VIVIX (27 years). LCBVX (1.23) is less costly to investors than VIVIX (0.04). LCBVX is a more actively managed with annual turnover of: 22.00 vs. VIVIX (9.00). LCBVX has a lower initial minimum investment than VIVIX: LCBVX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.27 vs. LCBVX (-6.81). VIVIX return over 5 years is better than : 63.59 vs. LCBVX (32.42).
LCBVXVIVIXLCBVX / VIVIX
Total Expense Ratio1.230.043,075%
Annual Report Gross Expense Ratio1.230.043,075%
Fund Existence11 years27 years-
Gain YTD-0.7281.452-50%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.27B184B1%
Annual Yield % from dividends0.712.2931%
Returns for 1 year-6.817.27-94%
Returns for 3 years7.8020.3038%
Returns for 5 years32.4263.5951%
Returns for 10 years41.10102.5940%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VALIX13.200.05
+0.38%
Value Line Capital Appreciation Investor
RSIPX14.52N/A
N/A
Columbia Disciplined Core Inst2
RYWAX49.65N/A
N/A
Rydex S&P SmallCap 600 Pure Growth H
JEMNX9.83N/A
N/A
JHancock Emerging Markets Equity R4
GQFPX12.14N/A
N/A
GQG Partners Global Quality Value Fd Inv